Brief: Zydus Lifesciences Enters Settlement Agreement With Astellas Over Myrbetriq
Feb 12 (Reuters) - Zydus Lifesciences Ltd ZYDU.NS: ZYDUS LIFESCIENCES - ENTERS SETTLEMENT AGREEMENT WITH ASTELLAS OVER MYRBETRIQ ZYDUS LIFESCIENCES - TO PAY ASTELLAS USD 120 MILLION ZYDUS LIFESCIENCES - TO PAY LICENSING FEE ON GENERIC MIRABEGRON ZYDUS LIFESCIENCES - SETTLEMENT CONCLUDES LITIGATIONS, ZYDUS TO MARKET GENERIC MIRABEGRON Source text: ID:nBSE4lWKCb Further company coverage: ZYDU.NS ((reuters.briefs@thomsonreuters.com;))
Recent news on Zydus Lifesciences
See all newsIndia's Zydus Lifesciences posts lower profit as expenses outpace revenue growth
Brief: Zydus Lifesciences Q2 Consol Net Profit 9.26 Billion Rupees
Brief: Zydus Lifesciences Says Zylidac Bio And Prolific Machines Partner
Brief: Zydus Lifesciences Receives U.S. FDA Approval For Estradiol And Levonorgestrel Transdermal System
Brief: Zydus Lifesciences Says Zydus Sunshine Lifesciences Signs Agreement To Establish A Pharmaceutical Manufacturing Facility In Sri Lanka